McLachlan, M., Bettcher, B., McVea, A., DiFilippo, A., Zammit, M., LeMerise, L., Rouanet, J., Price, J., Tudorascu, D., Laymon, C., Keator, D., Lao, P., Brickman, A. M., Fryer, T., Hartley, S., Ances, B. M., Rosas, H. D., Johnson, S., Betthauser, T., … Investigators, A. (2025). The striatum is an early, accurate indicator of amyloid burden using [11C]PiB in Down syndrome: Comparison of two radiotracers. Alzheimer’s & Dementia, 21(4). Portico. https://doi.org/10.1002/alz.70141

Jangard, S., Jayaram‐Lindström, N., Isacsson, N. H., Matheson, G. J., Plavén‐Sigray, P., Franck, J., Borg, J., Farde, L., & Cervenka, S. (2023). Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers. Addiction, 118(6), 1053–1061. Portico. https://doi.org/10.1111/add.16144

Reyes-Madrigal, F., Guma, E., León-Ortiz, P., Gómez-Cruz, G., Mora-Durán, R., Graff-Guerrero, A., Kegeles, L. S., Chakravarty, M. M., & de la Fuente-Sandoval, C. (2022). Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 113, 110473. https://doi.org/10.1016/j.pnpbp.2021.110473